The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global DXM and Codeine Syrup Market Research Report 2025
Synopsis
DXM and codeine syrup medicine help with symptoms of colds. these medicines can be safe and effective when they are taken as instructed.
The global DXM and Codeine Syrup market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for DXM and Codeine Syrup is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for DXM and Codeine Syrup is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of DXM and Codeine Syrup include Pfizer, Atley Pharmaceuticals, Vertical Pharmaceuticals, Novartis, Merck and Johnson & Johnson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for DXM and Codeine Syrup, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DXM and Codeine Syrup.
Report Scope
The DXM and Codeine Syrup market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DXM and Codeine Syrup market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DXM and Codeine Syrup manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Atley Pharmaceuticals
Vertical Pharmaceuticals
Novartis
Merck
Johnson & Johnson
Segment by Type
DXM
Promethazine-codeine Cough Syrup
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DXM and Codeine Syrup manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DXM and Codeine Syrup in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
DXM and codeine syrup medicine help with symptoms of colds. these medicines can be safe and effective when they are taken as instructed.
The global DXM and Codeine Syrup market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for DXM and Codeine Syrup is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for DXM and Codeine Syrup is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of DXM and Codeine Syrup include Pfizer, Atley Pharmaceuticals, Vertical Pharmaceuticals, Novartis, Merck and Johnson & Johnson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for DXM and Codeine Syrup, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DXM and Codeine Syrup.
Report Scope
The DXM and Codeine Syrup market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DXM and Codeine Syrup market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DXM and Codeine Syrup manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Atley Pharmaceuticals
Vertical Pharmaceuticals
Novartis
Merck
Johnson & Johnson
Segment by Type
DXM
Promethazine-codeine Cough Syrup
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DXM and Codeine Syrup manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DXM and Codeine Syrup in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 DXM and Codeine Syrup Market Overview
1.1 Product Overview and Scope of DXM and Codeine Syrup
1.2 DXM and Codeine Syrup Segment by Type
1.2.1 Global DXM and Codeine Syrup Market Value Comparison by Type (2024-2030)
1.2.2 DXM
1.2.3 Promethazine-codeine Cough Syrup
1.3 DXM and Codeine Syrup Segment by Application
1.3.1 Global DXM and Codeine Syrup Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Children
1.4 Global DXM and Codeine Syrup Market Size Estimates and Forecasts
1.4.1 Global DXM and Codeine Syrup Revenue 2019-2030
1.4.2 Global DXM and Codeine Syrup Sales 2019-2030
1.4.3 Global DXM and Codeine Syrup Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 DXM and Codeine Syrup Market Competition by Manufacturers
2.1 Global DXM and Codeine Syrup Sales Market Share by Manufacturers (2019-2024)
2.2 Global DXM and Codeine Syrup Revenue Market Share by Manufacturers (2019-2024)
2.3 Global DXM and Codeine Syrup Average Price by Manufacturers (2019-2024)
2.4 Global DXM and Codeine Syrup Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DXM and Codeine Syrup, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DXM and Codeine Syrup, Product Type & Application
2.7 DXM and Codeine Syrup Market Competitive Situation and Trends
2.7.1 DXM and Codeine Syrup Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest DXM and Codeine Syrup Players Market Share by Revenue
2.7.3 Global DXM and Codeine Syrup Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DXM and Codeine Syrup Retrospective Market Scenario by Region
3.1 Global DXM and Codeine Syrup Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global DXM and Codeine Syrup Global DXM and Codeine Syrup Sales by Region: 2019-2030
3.2.1 Global DXM and Codeine Syrup Sales by Region: 2019-2024
3.2.2 Global DXM and Codeine Syrup Sales by Region: 2025-2030
3.3 Global DXM and Codeine Syrup Global DXM and Codeine Syrup Revenue by Region: 2019-2030
3.3.1 Global DXM and Codeine Syrup Revenue by Region: 2019-2024
3.3.2 Global DXM and Codeine Syrup Revenue by Region: 2025-2030
3.4 North America DXM and Codeine Syrup Market Facts & Figures by Country
3.4.1 North America DXM and Codeine Syrup Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America DXM and Codeine Syrup Sales by Country (2019-2030)
3.4.3 North America DXM and Codeine Syrup Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe DXM and Codeine Syrup Market Facts & Figures by Country
3.5.1 Europe DXM and Codeine Syrup Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe DXM and Codeine Syrup Sales by Country (2019-2030)
3.5.3 Europe DXM and Codeine Syrup Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DXM and Codeine Syrup Market Facts & Figures by Country
3.6.1 Asia Pacific DXM and Codeine Syrup Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific DXM and Codeine Syrup Sales by Country (2019-2030)
3.6.3 Asia Pacific DXM and Codeine Syrup Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America DXM and Codeine Syrup Market Facts & Figures by Country
3.7.1 Latin America DXM and Codeine Syrup Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America DXM and Codeine Syrup Sales by Country (2019-2030)
3.7.3 Latin America DXM and Codeine Syrup Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DXM and Codeine Syrup Market Facts & Figures by Country
3.8.1 Middle East and Africa DXM and Codeine Syrup Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa DXM and Codeine Syrup Sales by Country (2019-2030)
3.8.3 Middle East and Africa DXM and Codeine Syrup Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global DXM and Codeine Syrup Sales by Type (2019-2030)
4.1.1 Global DXM and Codeine Syrup Sales by Type (2019-2024)
4.1.2 Global DXM and Codeine Syrup Sales by Type (2025-2030)
4.1.3 Global DXM and Codeine Syrup Sales Market Share by Type (2019-2030)
4.2 Global DXM and Codeine Syrup Revenue by Type (2019-2030)
4.2.1 Global DXM and Codeine Syrup Revenue by Type (2019-2024)
4.2.2 Global DXM and Codeine Syrup Revenue by Type (2025-2030)
4.2.3 Global DXM and Codeine Syrup Revenue Market Share by Type (2019-2030)
4.3 Global DXM and Codeine Syrup Price by Type (2019-2030)
5 Segment by Application
5.1 Global DXM and Codeine Syrup Sales by Application (2019-2030)
5.1.1 Global DXM and Codeine Syrup Sales by Application (2019-2024)
5.1.2 Global DXM and Codeine Syrup Sales by Application (2025-2030)
5.1.3 Global DXM and Codeine Syrup Sales Market Share by Application (2019-2030)
5.2 Global DXM and Codeine Syrup Revenue by Application (2019-2030)
5.2.1 Global DXM and Codeine Syrup Revenue by Application (2019-2024)
5.2.2 Global DXM and Codeine Syrup Revenue by Application (2025-2030)
5.2.3 Global DXM and Codeine Syrup Revenue Market Share by Application (2019-2030)
5.3 Global DXM and Codeine Syrup Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer DXM and Codeine Syrup Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer DXM and Codeine Syrup Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Atley Pharmaceuticals
6.2.1 Atley Pharmaceuticals Corporation Information
6.2.2 Atley Pharmaceuticals Description and Business Overview
6.2.3 Atley Pharmaceuticals DXM and Codeine Syrup Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Atley Pharmaceuticals DXM and Codeine Syrup Product Portfolio
6.2.5 Atley Pharmaceuticals Recent Developments/Updates
6.3 Vertical Pharmaceuticals
6.3.1 Vertical Pharmaceuticals Corporation Information
6.3.2 Vertical Pharmaceuticals Description and Business Overview
6.3.3 Vertical Pharmaceuticals DXM and Codeine Syrup Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Vertical Pharmaceuticals DXM and Codeine Syrup Product Portfolio
6.3.5 Vertical Pharmaceuticals Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis DXM and Codeine Syrup Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis DXM and Codeine Syrup Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck DXM and Codeine Syrup Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck DXM and Codeine Syrup Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson DXM and Codeine Syrup Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson DXM and Codeine Syrup Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DXM and Codeine Syrup Industry Chain Analysis
7.2 DXM and Codeine Syrup Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DXM and Codeine Syrup Production Mode & Process
7.4 DXM and Codeine Syrup Sales and Marketing
7.4.1 DXM and Codeine Syrup Sales Channels
7.4.2 DXM and Codeine Syrup Distributors
7.5 DXM and Codeine Syrup Customers
8 DXM and Codeine Syrup Market Dynamics
8.1 DXM and Codeine Syrup Industry Trends
8.2 DXM and Codeine Syrup Market Drivers
8.3 DXM and Codeine Syrup Market Challenges
8.4 DXM and Codeine Syrup Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
